ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 09 Dec 2024
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
97759298 filed on 18th Jan 2023
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IMDELLTRA
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97759298
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-2233-US-1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.15 -
Four or more triangles
26.05.16 -
Triangles touching or intersecting
26.05.21 -
Triangles that are completely or partially shaded
26.05.25 -
Triangles with one or more curved sides
26.17.12 -
Chevrons and angles
27.03.05 -
Representations of objects forming letters or numerals, including punctuation
29.01.07 -
Small, inconspicuous design elements functioning as punctuation or parts of letters
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Dec 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 09th Dec 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 07th May 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Mar 2024 | PUBLISHED FOR OPPOSITION |
| 21st Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 06th Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 05th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |